The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss. - Zheng T; Kang JH; Sim JS; Kim JW; Koh JT; Shin CS; Lim H; Yim M (Oncotarget, 2017)